| Blog results | Results 1 - 10 of about 39,102 for drug more plavix use. (0.22 seconds) |
| Sorted by relevance Sort by date |
| 18 Nov 2009 The US Food and Drug Administration this week issued a new warning to healthcare providers and patients against the concomitant use of the anti-platelet agent Plavix (clopidogrel) and CYP2C19-inhibiting agents, but the agency simultaneously acknowledged that there ... Under its Genetics for Generics program, the pharmacy benefit manager is planning to offer genetic testing to its customers to encourage more efficient administration of Plavix [see PGx Reporter 10-7-2009]. ... Überfeed of All GenomeWeb Content - http://feeds.genomeweb.com/genomeweb [ More results from Überfeed of All GenomeWeb Content ] |
| 15 Nov 2009 by Deborah Mitchell An experimental anti-clotting drug being developed by AstraZeneca was shown to be more effective than Plavix® (clopidogrel) in treating heart patients who have the most serious type of acute coronary. ... Ticagrelor did not cause an increase in major bleeding (9.0%) when compared with clopidogrel (9.3%). Use of ticagrelor was also associated with an 18 percent reduction in all cause mortality at one year compared with clopidogrel. Patients who have STEMI need to undergo ... Emaxhealth - http://www.emaxhealth.com/ |
| 18 Nov 2009 by Tangaroa Snell The speculations regarding potent stomach-acid-reducing drug Prilosec reducing the benefit of plavix but data from more recent studies indicated that Prilosec and a similar drug Nexium might help patients on Plavix. ... TopNews New Zealand - http://topnews.net.nz/ - References |
| 19 Nov 2009 by The Happy Hospitalist Other than Cimetidine (Tagamet), the answer is no. These drugs are not known to affect the efficacy of Plavix. As medicine becomes more complicated, relying on your friendly neighborhood pharmacist to flag potentially deadily drug ... The Happy Hospitalist - http://thehappyhospitalist.blogspot.com/ [ More results from The Happy Hospitalist ] |
| 19 Nov 2009 The submission to the FDA is based on the phase 3 Plato study done by AstraZeneca comparing Brilinta plus aspirin with Plavix plus aspirin. Results of the 18624-patient study showed that Brilinta was more effective than Plavix in treating patients ... With patent expirations rapidly approaching, Big Pharma can't risk losing even a small fraction of its blockbuster drug revenues to rivals. Plavix, developed jointly by Bristol-Myers Squibb (BMY) and Sanofi-Aventis (SNY), ... Minyanville - http://www.minyanville.com/ [ More results from Minyanville ] |
| 19 Nov 2009 by Opieswifey [ More Some Heartburn Drugs Interact With Plavix News from Google]. == Related WisdomCards==*[[]]. [[]]; [[]]; [[]]; [[]]; [[]]; [[]]; [[]]; [[]]; [[]]. About this WisdomCard. Contributor: Unclaimed; Reviewer: Unclaimed; Last update: ... OrganizedWisdom Health - Stroke and Mini-Stroke - http://organizedwisdom.com/Category:Stroke_and_... |
| 17 Nov 2009 by AP Information about the drug interaction between Plavix and certain heartburn medications is not new. In January, Sanofi and Bristol-Myers updated Plavix's labeling to advise against using it in combination with certain heartburn ... November 10th, 2009 more images more imagesTeva gets FDA approval for generic PrevacidNEW YORK — Teva Pharmaceutical Industries Ltd. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid. ... Health News - http://blog.taragana.com/health/ - References [ More results from Health News ] |
| 18 Nov 2009 by Anna Tomova The US Food and Drug Administration (FDA) has issued a warning to patients, asking them not to combine Plavix with Nexium, Prilosec, including 9-other drugs like Prozac and Tagamet. According to FDA, such a combination of drugs would ... Visit Bulgaria - http://visitbulgaria.info/ [ More results from Visit Bulgaria ] |
| 18 Nov 2009 by c.morrison@elsevier.com (Chris Morrison) The Food & Drug Administration's public health alert on Plavix is, as we point out in "The Pink Sheet" DAILY, a nice boost for Eli Lilly and Daiichi Sankyo, who market the competing platelet agent Effient. ... What is news is that FDA has decided that information is now a formal warning, rather than a milder precaution--and, more importantly, the agency chose to amplify that warning (especially regarding PPI use) via a media conference call. ... The IN VIVO Blog - http://invivoblog.blogspot.com/ - References [ More results from The IN VIVO Blog ] |
| 19 Nov 2009 Medco is getting ready for generic Plavix, and trying to keep its costs down by making the case that the drug will do the job just fine for most patients. They could, on the other hand, end up making the case for Effient in that .... If people were selfless, then the gap from the first stage to the second wouldn't occur (people would be willing to product more output than their needs mandate for others), and people who need more than they can produce would try harder to ... In the Pipeline - http://pipeline.corante.com/ - References |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |